Gene Query: NOMO1

Dataset Description Geneva Score
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 40.45
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 39.41
Targeting EZH2 in MYCN-amplified Neuroblastoma 39.41
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 39.24
RNA-seq analysis of AML cells in response to ASLAN003 38.63
Silencing SPIB in attached and floating state of H1703 lung cancer cells 37.08
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 35.48
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 31.59
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 30.95
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 30.44
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 29.9
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 29.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 29.42
Pharmacologic inhibition of STAT5 in AML 25.05
A role for ZNF598 in post-transcriptional gene regulation 25.01
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 24.91
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 24.53
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 24.36
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 24.24
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 23.37
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 23.24
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 22.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 22.42
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 22.23
Regulation of highly expressed hCINAP on translatome 21.64
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 21.0
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 20.82
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 20.37
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 19.93
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 19.59
Regionally specified human pluripotent stem cell-derived astrocytes 19.3
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 19.26
Morphological and molecular characterization of human dermal lymphatic collectors 18.84
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 18.76
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 18.61
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 18.45
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 18.45
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 18.1
HNF1A deficiency impairs β-cell fate, granule maturation and function 18.07
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 18.04
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 17.99
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 17.98
Transcriptome analysis in Neobractatin treated cells 17.59
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 17.59
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 17.42
Modeling Familial Cancer with iPSC Approaches 16.83
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 16.82
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 16.79
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 16.76
Genome wide miR-191 target profile determined by RIP and gene expression profiling 16.76
TT-Seq captures the human transient transcriptome 16.5
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 15.8
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.77
RNA-Seq analysis of breast cancer cells after shikonin treatment 15.67
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 14.93
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 14.89
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 14.86
Sensing self and nonself circular RNAs 14.85
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 14.76
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 14.75
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 14.52
Systematic discovery of endogenous human ribonucleoprotein complexes 14.47
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 14.41
PNET animal model: new insights (II) 14.08
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 13.98
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 13.98
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 13.64
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 13.64
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 13.61
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 13.4
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 13.36
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.19
Mitochondrial dsRNA triggers antiviral signalling in humans 13.14
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 12.54
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 12.47
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.46
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 12.42
GATA3-mediated chromatin reprogramming in breast cancer cells 12.19
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 12.16
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 12.16
3’ Uridylation Expands miRNA Target Repertoire 12.15
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 12.12
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 12.12
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 12.09
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 12.02
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 11.72
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 11.72
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 11.69
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 11.62
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 11.55
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 11.49
Role of CD133 molecule in WNT response and renal repair 11.45
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 11.31
circRNA-sequencing 11.31
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.25
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.18
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.0
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 10.96
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.92
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 10.68
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 10.68
The human blood-nerve barrier transcriptome 10.67
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 10.66
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 10.65
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 10.65
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.62
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 10.5
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 10.5
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 10.49
Genome-wide functional assessment of enhancer activities in the human genome 10.4
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 10.39
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.32
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.32
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.3
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 10.14
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 10.09
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 10.09
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.09
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 10.09
DJ-1 is dispensable for human stem cell homeostasis 9.95
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.92
Functional role of SLIT2 and ROBO1 in trophoblasts 9.92
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 9.89
The role of CFTR in islet function 9.81
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 9.75
T47D RNA-seq and ChrRNA-seq data 9.75
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 9.73
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.71
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.71
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.7
Determining mRNA half-lives on a transcriptome-wide scale 9.66
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.65
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 9.64
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 9.64
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 9.56
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 9.51
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 9.5
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.48
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.36
O-glcnAc reprograms cellular energetics 9.34
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.33
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.32
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 9.28
Identification of Atrial Fibrillation associated genes and functional non-coding variants 9.26
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 9.23
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 9.16
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.15
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 9.11
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 9.07
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 9.0
Gene expression analysis of breast cancer cell-lines 8.98
Gene expression and genome-wide location analysis of breast cancer cell-lines 8.98
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.95
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.95
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 8.92
m6A-dependent regulation of messenger RNA stability 8.9
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 8.88
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 8.86
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 8.85
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.85
RNA transcriptome analysis during HSV-1 infection 8.79
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.78
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 8.68
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 8.63
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.53
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.5
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.5
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 8.47
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.29
Expression profiling of MCF-7 cells with treatment of TCDD 8.27
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 8.27
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 8.27
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.23
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.19
Characterization of parental and rociletinib-resistant derived H1975 cell lines 8.17
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.16
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.16
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.16
RNA m5C Methylation in breast cancer using MeRIP-Seq 8.12
Exploring the RNA landscape of endothelial exosomes 8.1
MEIS1 regulates hematopoiesis in hPSCs 8.04
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.03
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.94
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 7.89
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 7.88
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.87
METTL3 and WTAP 7.86
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 7.85
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.84
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 7.8
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 7.79
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 7.79
Gene expression profile of human placenta from T. Cruzi infected mothers 7.77
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.75
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 7.69
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 7.69
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.66
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 7.61
Postnatal lipids drive hepatocyte maturation 7.56
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.5
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 7.49
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 7.42
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 7.39
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.37
hnRNP C is a key regulator of protein synthesis in mitosis 7.36
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 7.34
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.27
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.19
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.19
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 7.18
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 7.15
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.15
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 7.09
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 7.08
RNA seq comparison between scrambled and shGRP78 cells 7.08
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.98
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.97
Selective expression of long non-coding RNAs in a breast cancer cell progression model 6.96
Expression profiling of etoposide-induced senescent cells 6.94
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.89
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 6.85
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.8
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 6.79
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 6.71
Alteration of the microRNA network during the progression of Alzheimer’s disease 6.69
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.69
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 6.68
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 6.67
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 6.67
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.61
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.55
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.54
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.52
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.52
Enhancer activation during EGF response 6.51
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 6.47
mRNA expression in human DAOY cells 6.45
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 6.45
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 6.45
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.42
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.37
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.25
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.2
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.19
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.19
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 6.19
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 6.19
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 6.18
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.14
Landscape and variation of RNA secondary structure across the human transcriptome 6.13
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 6.09
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 6.09
mRNA recovered upon RNF219 IP. [RNA-IP] 6.08
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.06
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 6.02
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 6.0
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.93
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 5.91
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 5.91
RNA-seq melanoma 5.9
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 5.9
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.72
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.72
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 5.71
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.7
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 5.69
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.63
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 5.58
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 5.56
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 5.56
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 5.55
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.51
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.51
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 5.47
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 5.46
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.45
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.41
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 5.4
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.39
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.39
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.39
Gene expression profiling of KSHV-infected periodontal ligament cells 5.34
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.33
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.33
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 5.32
Positively selected enhancer elements endow tumor cells with metastatic competence 5.32
circRNA profile in hypopharyngeal cancer 5.32
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.31
Hepatosplenic T cell lymphoma 5.19
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.19
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 5.09
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.01
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.92
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.91
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.87
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.85
miR-93 Targets in Human Endothelial Cells 4.81
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.79
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 4.74
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 4.69
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 4.68
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 4.68
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.66
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.6
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.55
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.55
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.55
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 4.42
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.4
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.23
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 4.2
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 4.14
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.12
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.07
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.05
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.01
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 3.99
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 3.99
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.99
Transcriptome analysis upon C6orf203 silencing 3.99
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.97
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 3.92
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.9
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.89
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.88
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.83
Clinker: visualizing fusion genes detected in RNA-seq data 3.76
The transcriptome and chromatin accessbility landscape of mammalian germline 3.75
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.74
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.74
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.71
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.63
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 3.58
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.54
RNA-sequencing in irradiated and normal A549 cells. 3.53
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.5
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 3.5
RNAseq in Alzheimer's Disease patients 3.48
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.44
Induced DNA demethylation, genome instability and transcription 3.39
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.39
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.35
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.34
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.34
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.33
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.31
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 3.3
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 3.3
Evaluating pre-clinical models for studying NASH driven HCC. 3.27
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.26
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.25
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.23
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 3.21
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.2
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.2
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.16
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.15
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.13
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.13
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.11
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.09
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.09
RNA-seq analysis of gene expression patterns during hESC neural differentiation 3.08
hESC neural differentiation 3.08
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.04
RNA-seq of RKO cells with cTAZ KO or putback 2.99
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.87
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.82
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.81
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.8
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.74
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.72
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.71
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.69
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.69
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.65
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.64
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.64
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 2.64
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 2.64
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.6
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.57
Profiling of escape kinetics of viruses subjected to RNAi 2.54
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.46
An optimization system for isolating and sequencing of single human colon cancer cells 2.45
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 2.45
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.44
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.44
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.43
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.43
Transcription elongation regulates genome 3D structure 2.4
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.39
6mer seed toxicity in viral microRNAs 2.33
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.31
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.3
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.3
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.28
KSDM1b Role in Ewing Sarcoma 2.25
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.19
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.18
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.16
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.11
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 2.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.0
Modeling Human Cancer-induced Cachexia (Human) 1.96
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.9
Hepatic transcriptome of pediatric hepatoblastoma. 1.86
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.85
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.78
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.75
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.73
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.73
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.72
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.72
RNA Sequencing of Human iPS derived Cardiomyocytes 1.69
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.68
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.66
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.66
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.59
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.58
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.53
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.53
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.51
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.47
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.44
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.44
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.44
Gene expression profiling of papillary thyroid cancer from central and invasive regions 1.43
Direct Isolation and Characterization of Human Nephron Progenitors. 1.39
Tracking distinct RNA populations using efficient and reversible covalent chemistry 1.31
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.28
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.27
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.13
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.13
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.09
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.09
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.09
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.05
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 1.05
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.04
Effect of ILF3 on translation during homeostasis and the antiviral response 1.04
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.01
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.0
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.0
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.0
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.94
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.89
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.89
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.84
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.83
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.81
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.81
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.75
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.7
Ribosome profiling upon inhibition of eIF4A 0.67
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.66
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.66
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.63
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.63
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.6
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.56
K562 polyA RNA-Seq 0.52
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.52
Transcriptome Profiling of Human Primary Monocytes 0.5
RNA-seq of IL-4 stimulated human keratinocytes 0.49
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.48
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.47
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.44
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.43
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.35
Transcriptomic profiling of human peripheral blood-derived mast cells 0.35
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.33
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.29
The pioneer factor CEBPA modulates vitamin D signaling 0.29
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.25
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.25
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.24
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.22
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.22
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.2
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.18
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.18
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.17
The role of m6A/m-RNA methylation in stress response regulation 0.17
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.16
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.16
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.16
Dilated cardiomyopathy vs Myocarditis 0.12
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.11
Myc activation coordinates gene transcription and protein translation responses 0.11
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.11
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.09
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.05
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.0
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.0
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation